Is Quest Diagnostics Incorporated overvalued?

Quest Diagnostics Incorporated (DGX) looks overvalued — trading about 36% above its fair value.

Overvalued

Price

$237.77

Fair value

$153.20

Current P/E

27.2

Normal P/E

17.5

Market cap

$26.24B

Dividend yield

1.4%

Return on equity

14.5%

Sector

Healthcare

Fair value compares DGX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks